Federal Judge Allows Mifepristone Mail Orders Pending FDA Review

A federal judge ruled that the abortion pill mifepristone remains available for mail orders while an FDA safety review proceeds. This decision maintains current access despite ongoing legal challenges regarding telehealth restrictions in states like Louisiana. The ruling highlights the tension between federal guidelines and state-level abortion bans during a critical review period.